Visalytics
Visalytics
approved EB-2 (NIW)

Regulatory Chemist

Pharmaceuticals · India · 2025-07-30

Processing Time
47 days
Decision Date
2025-07-30
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical challenges such as high drug prices and sluggish development cycles, which are of significant interest to U.S. public health.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record, citation metrics, and expert recognition demonstrate her ability to successfully drive pharmaceutical innovation.

3 Waiver of Job Offer and Labor Certification Met

On balance, the petitioner's unique expertise in streamlining the drug approval process provides benefits to the U.S. that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 7 peer-reviewed journal articles and 1 book chapter, which garnered 33 citations. Evidence showed her research ranked in the top 20% of most-cited publications in her field for its release year. The case satisfied all three Dhanasar prongs by demonstrating the national importance of making medications more affordable and accessible.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Reference Letters Dependent
Original Contributions
Government Alignment

Similar Cases

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) rfe approved
North Carolina 111 days 2025-02-08
The petitioner proposes to improve existing therapies by applying advanced pharmaceutical principles to commercialize biopharmaceuticals and pharmaceuticals. The work focuses on developing innovative drug solubility enhancement methods and non-invasive oral drug delivery systems to treat serious diseases like cancer, AIDS, and kidney failure.
View Case

Others

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Michigan 469 days 2025-02-20
The petitioner proposes to advance analytical techniques crucial for monitoring pharmaceutical quality across drug discovery, manufacturing, and clinical evaluation stages. Her work focuses on developing and optimizing analytical methods to ensure the safety, consistency, and potency of treatments for cancer and chronic conditions. This endeavor aims to improve medication validation processes and enhance the reliability of drug quality assurance.
View Case

Others

Pharmaceuticals · Indonesia

WeGreened EB-2 (NIW) approved
Kentucky 634 days 2025-10-28
The petitioner proposes to streamline pre-formulation and formulation processes to enhance oral drug delivery and pharmaceutical manufacturing efficiency. This work utilizes advanced materials science techniques for pharmaceutical characterization to improve patient outcomes and create sustainable production practices. The endeavor aims to advance critical life-sciences technology sectors within the U.S. healthcare system.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-07-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 47 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist